Mechanistic and Pharmacokinetic Characterization of CAL101, a Novel Anti-S100A4 Antibody for Fibrotic Indications

Publikation: Bog/antologi/afhandling/rapport › Ph.d.-afhandling

Originalsprog	Engelsk

Vejledere: Jesper T. Troelsen (RUC), Dr. Jörg Klingelhöfer (Calluna Pharma) & Dr. Jonas Hallén (Calluna Pharma)

Citationsformater

@phdthesis{5697addc4a2c47a6a27c334d20811f80,

title = "Mechanistic and Pharmacokinetic Characterization of CAL101, a Novel Anti-S100A4 Antibody for Fibrotic Indications",

author = "Borchert, \{Signe Vedel\}",

note = "Vejledere: Jesper T. Troelsen (RUC), Dr. J{\"o}rg Klingelh{\"o}fer (Calluna Pharma) \& Dr. Jonas Hall{\'e}n (Calluna Pharma)",

year = "2025",

language = "English",

publisher = "Roskilde Universitet",

}

TY - BOOK

T1 - Mechanistic and Pharmacokinetic Characterization of CAL101, a Novel Anti-S100A4 Antibody for Fibrotic Indications

AU - Borchert, Signe Vedel

N1 - Vejledere: Jesper T. Troelsen (RUC), Dr. Jörg Klingelhöfer (Calluna Pharma) & Dr. Jonas Hallén (Calluna Pharma)

PY - 2025

Y1 - 2025

M3 - Ph.D. thesis

BT - Mechanistic and Pharmacokinetic Characterization of CAL101, a Novel Anti-S100A4 Antibody for Fibrotic Indications

PB - Roskilde Universitet

CY - Roskilde

ER -